Drug Trial Radar · NCT07650942
Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Jun 2026
Primary completion
May 2028
Study completion Feb 2029
Sponsor
- Lead sponsor
- Ganzhou Hemay Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jun 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this phase III, multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safety of Hemay005 compared to placebo as induction and maintenance therapy in Chinese participants with moderately to severely active ulcerative colitis.
Conditions
- Ulcerative Colitis (UC)
Interventions
Hemay005 tabletDrug
Participants receive treatment with Hemay005 tablet during the Induction Phase (week I-0\~I-12).
PlaceboDrug
Participants receive treatment with placebo tablet during the Induction Phase (week I-0\~I-12).
Hemay005 tabletDrug
Participants receive treatment with Hemay005 tablet during the Maintenance Phase (week M-0\~M-40).
PlaceboDrug
Participants receive treatment with placebo during the Maintenance Phase (week M-0\~M-40).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Induction Phase: Percentage of Participants With Clinical Remission at Week 12.Time frame: Induction Phase Week 12
- Maintenance Phase: Percentage of Participants With Clinical Remission at Week 40.Time frame: Maintenance Phase: Week 40
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital,Sun Yat-Sen University
Guangzhou, China
The Sixth Affiliated Hospital,Sun Yat-Sen University
Guangzhou, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.